# Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/vedolizumab-therapy-is-ineffective-for-primary-sclerosing-cholangitis-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Bénédicte Caron,Laurent Peyrin‐Biroulet,Benjamin Pariente,Yoram Bouhnik,Philippe Seksik,Guillaume Bouguen,Ludovic Caillo,David Laharie,Franck Carbonnel,Romain Altwegg,Cathérine Reenaers,Mélanie Serrero,Caroline Trang-Poisson,Stéphane Nancey,Jerome Filippi,Véred Abitbol,Guillaume Savoye,Lucine Vuitton,Stéphanie Viennot,Mathurin Fuméry,Maud Reymond,Jean–Pierre Bronowicki,Jean‐Marie Reimund,Aurélien Amiot |
| Citations | 58 |
| DOI | 10.1093/ecco-jcc/jjz088 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/ecco-jcc/article-pdf/13/10/1239/30104618/jjz088.pdf |
| OpenAlex ID | https://openalex.org/W2944756700 |
| PMID | 31056693 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Ludovic Caillo](https://scholariq.org/researchers/ludovic-caillo/)

## Paper journal

- [Journal of Crohn s and Colitis](https://scholariq.org/journals/journal-of-crohn-s-and-colitis/)

## Paper primary topic

- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

## Paper topics

- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.